519 related articles for article (PubMed ID: 31622129)
21. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.
Rubino C; Shamsaldin A; Lê MG; Labbé M; Guinebretière JM; Chavaudra J; de Vathaire F
Breast Cancer Res Treat; 2005 Feb; 89(3):277-88. PubMed ID: 15754127
[TBL] [Abstract][Full Text] [Related]
22. Variation of second cancer risk by family history of retinoblastoma among long-term survivors.
Kleinerman RA; Yu CL; Little MP; Li Y; Abramson D; Seddon J; Tucker MA
J Clin Oncol; 2012 Mar; 30(9):950-7. PubMed ID: 22355046
[TBL] [Abstract][Full Text] [Related]
23. Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients.
Virtanen A; Pukkala E; Auvinen A
Int J Cancer; 2006 Feb; 118(4):1017-21. PubMed ID: 16152578
[TBL] [Abstract][Full Text] [Related]
24. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma.
Abramson DH; Melson MR; Dunkel IJ; Frank CM
Ophthalmology; 2001 Oct; 108(10):1868-76. PubMed ID: 11581064
[TBL] [Abstract][Full Text] [Related]
25. Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe.
Fidler MM; Reulen RC; Winter DL; Allodji RS; Bagnasco F; Bárdi E; Bautz A; Bright CJ; Byrne J; Feijen EAM; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Haddy N; Jankovic M; Kaatsch P; Kaiser M; Kuonen R; Linge H; Maule M; Merletti F; Øfstaas H; Ronckers CM; Skinner R; Teepen J; Terenziani M; Vu-Bezin G; Wesenberg F; Wiebe T; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuehni CE; Winther JF; de Vathaire F; Kremer LC; Hjorth L; Hawkins MM
J Natl Cancer Inst; 2018 Feb; 110(2):. PubMed ID: 28954302
[TBL] [Abstract][Full Text] [Related]
26. Retinoblastoma survivors: sarcomas and surveillance.
Meadows AT
J Natl Cancer Inst; 2007 Jan; 99(1):3-5. PubMed ID: 17202103
[No Abstract] [Full Text] [Related]
27. Cancer mortality in long-term survivors of retinoblastoma.
Marees T; van Leeuwen FE; de Boer MR; Imhof SM; Ringens PJ; Moll AC
Eur J Cancer; 2009 Dec; 45(18):3245-53. PubMed ID: 19493675
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
30. Risk of sarcoma increased in survivors of retinoblastoma.
Cumber H
Lancet Oncol; 2007 Feb; 8(2):104. PubMed ID: 17290506
[No Abstract] [Full Text] [Related]
31. Subsequent tumors in retinoblastoma survivors: the role of the head and neck surgeon.
de Bree R; Moll AC; Imhof SM; Buter J; Leemans CR
Oral Oncol; 2008 Oct; 44(10):982-5. PubMed ID: 18280773
[TBL] [Abstract][Full Text] [Related]
32. Osteosarcoma following retinoblastoma: age at onset and latency period.
Chauveinc L; Mosseri V; Quintana E; Desjardins L; Schlienger P; Doz F; Dutrillaux B
Ophthalmic Genet; 2001 Jun; 22(2):77-88. PubMed ID: 11449317
[TBL] [Abstract][Full Text] [Related]
33. Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy.
Mohney BG; Robertson DM; Schomberg PJ; Hodge DO
Am J Ophthalmol; 1998 Aug; 126(2):269-77. PubMed ID: 9727521
[TBL] [Abstract][Full Text] [Related]
34. Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk?
Moll AC; Imhof SM; Schouten-Van Meeteren AY; Kuik DJ; Hofman P; Boers M
Ophthalmology; 2001 Jun; 108(6):1109-14. PubMed ID: 11382638
[TBL] [Abstract][Full Text] [Related]
35. Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type.
Wu LC; Kleinerman RA; Curtis RE; Savage SA; Berrington de González A
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1993-9. PubMed ID: 22964827
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.
Hawkins MM; Wilson LM; Burton HS; Potok MH; Winter DL; Marsden HB; Stovall MA
J Natl Cancer Inst; 1996 Mar; 88(5):270-8. PubMed ID: 8614005
[TBL] [Abstract][Full Text] [Related]
37. Second primary tumors in patients with retinoblastoma. A review of the literature.
Moll AC; Imhof SM; Bouter LM; Tan KE
Ophthalmic Genet; 1997 Mar; 18(1):27-34. PubMed ID: 9134547
[TBL] [Abstract][Full Text] [Related]
38. Ionizing radiation exposure and the development of soft-tissue sarcomas in atomic-bomb survivors.
Samartzis D; Nishi N; Cologne J; Funamoto S; Hayashi M; Kodama K; Miles EF; Suyama A; Soda M; Kasagi F
J Bone Joint Surg Am; 2013 Feb; 95(3):222-9. PubMed ID: 23389785
[TBL] [Abstract][Full Text] [Related]
39. [Bone sarcoma and malignant tumors of the retina].
Schlienger P; Calle R; Haye C; Vilcoq JR
Bull Cancer; 1985; 72(1):16-24. PubMed ID: 3857081
[TBL] [Abstract][Full Text] [Related]
40. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
